| DCAPI1560 |
Sitagliptin phosphate
|
Sitagliptin phosphate, an orally active agent, potently inhibits CD26 (DPP-4) with an IC50 of 19 nM. Sitagliptin performs a direct, novel action in order to stimulate GLP-1 secretion by the intestinal L cell through a DPP-4-independent, protein kinase A- |
| DCAPI1552 |
streptomycin
|
streptomycin |
| DCAPI1520 |
S-adenosyl-L-methionine
|
S-adenosyl-L-methionine |
| DCAPI1436 |
Milbemycin oxime
|
Milbemycin oxime is a semi-synthetic macrocyclic lactone prepared by the oxidation and oximation of a mixture of two natural products, milbemycin A3 and A4 (in ~70: 30 ratio). Moxidectin oxime, marketed as Interceptor, is used therapeutically for the prev |
| DCAPI1425 |
Anastrozole
|
Anastrozole is known to inhibit the CYP19 enzyme (aromatase, IC50 = 15 nM) that converts androgens to estrogens. Anastrozole has been seen to reversibly bind to the CYP19 enzyme through competitive inhibition. |
| DCAPI1398 |
Disulfiram (Antabuse)
|
Disulfiram (Antabuse) |
| DCAPI1393 |
Nedaplatin (Aqupla)
|
Nedaplatin (Aqupla) is a derivative of cisplatin for inhibition of tumor colony forming units with IC50 of 28.5 μg/mL. |
| DCAPI1391 |
Ranolazine (Ranexa)
|
Ranolazine (Ranexa) |
| DCAPI1374 |
Cyclovirobuxin D(Bebuxine)
|
Cyclovirobuxin D(Bebuxine) |
| DCAPI1231 |
Salinomycin (Procoxacin)
|
For the detailed information of Salinomycin (Procoxacin), the solubility of Salinomycin (Procoxacin) in water, the solubility of Salinomycin (Procoxacin) in DMSO, the solubility of Salinomycin (Procoxacin) in PBS buffer, the animal experiment（test） (test) |
